ASND
NASDAQ HealthcareAscendis Pharma A/S - Ordinary Share
Biotechnology
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
�� 市场数据
| 价格 | $220.93 |
|---|---|
| 成交量 | 453,447 |
| 市值 | 13.65B |
| 贝塔系数 | 0.480 |
| RSI（14日） | 28.5 超卖 |
| 200日均线 | $210.25 |
| 50日均线 | $231.14 |
| 52周最高 | $250.74 |
| 52周最低 | $150.89 |
| Forward P/E | 24.68 |
| Price / Book | -71.04 |
🎯 投资策略评分
ASND 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (79/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🎈 Over-Hyped (4/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 ASND in your text
粘贴任何文章、记录或帖子 — 工具将提取 ASND 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-05-01.